Matt Wetzel is an experienced health care fraud and abuse and compliance lawyer. He provides strategic advice to life sciences companies on complex health care laws and regulations, including federal and state fraud and abuse laws, billing and reimbursement regulations, and transparency requirements, among other areas. Mr. Wetzel also establishes and aids clients in operating effective compliance programs.

Mr. Wetzel brings a unique, 360-degree perspective of the legal and compliance issues affecting life sciences companies. As a veteran of the medtech industry, he brings a pragmatic approach to counseling his clients. Prior to joining Goodwin, Mr. Wetzel served as Chief Compliance Officer of a Silicon Valley biotech start-up; was the Vice President & Deputy General Counsel of the world’s largest medical technology trade association in Washington, DC; and held an executive legal role at a multinational medical device maker.

Areas of Practice
业务范围
Domaines D’Expertise
TÄTIGKEITSFELDER

Experience

工作经历

EXPÉRIENCE

ERFAHRUNG

Mr. Wetzel counsels medical device and diagnostics manufacturers, laboratory testing companies, pharmaceutical and biotech companies, and a variety of other health care and life sciences organizations. Mr. Wetzel analyzes complex business arrangements under the Federal Anti-Kickback Statute and state equivalents, the Stark Law, the Beneficiary Inducement Law, the False Claims Act, the Sunshine Act and other laws. He helps structure financial and remunerative relationships with customers and other health care providers, including strategic counseling on sales and marketing practices, innovative value-based arrangements, and discounting and pricing practices. He also conducts due diligence in the context of mergers and acquisitions, IPOs, and financing transactions.

Leveraging his extensive in-house experience in both the multinational setting and the start-up environment, Mr. Wetzel works with clients to develop and implement effective compliance programs. This includes drafting policies and internal control documents; training employees and agents on appropriate customer interactions; conducting risk assessments and audits to help identify potential vulnerabilities or gaps; conducting internal investigations in response to allegations of wrongdoing; and offering strategic guidance on the evolution and growth of life sciences companies’ compliance programs.

Mr. Wetzel’s unique experience also gives clients deep benchmarking insight and a comprehensive view of industry best practices in a variety of areas. As Vice President & Deputy General Counsel at AdvaMed, Mr. Wetzel spearheaded the medical technology’s most recent revisions to the longstanding AdvaMed US Code of Ethics. He also oversaw the launch of the AdvaMed Code of Ethics in China.

Mr. Wetzel also represents health care clients before key federal and state policymakers, including Congress, the Centers for Medicare and Medicaid Services, and the US Department of Health & Human Services Office of the Inspector General.

Mr. Wetzel is an expert contributor to the Washington Legal Foundation where he writes about life sciences, medtech regulation, healthcare law, and government regulation.

Below are links to his articles:

Mr. Wetzel’s recent experience includes representation of:

Transactions

  • CPS Solutions, LLC, a Frazier Healthcare portfolio company and one of the nation’s largest pharmacy and hospital services providers, in its $780 million acquisition of Trellis Rx, LLC, a technology-enabled specialty pharmacy service provider.

  • Senti Biosciences, Inc. in its business combination with Dynamics Special Purpose Corp., a special purpose acquisition company.

  • The purchaser in connection with Cutera, Inc.’s $230,000,000 offering of % convertible notes. Cutera is a leading provider of aesthetic and dermatology solutions for medical practitioners worldwide.

  • Symeres, one of the largest European small molecule CRO & CDMOs, in its acquisition of Organix, a specialized organic chemistry services provider.
  • Clarus Therapeutics, a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women, in its public offering of shares of common stock 
  • Altasciences in its acquisition of Valley Biosystems, a non-human primate (NHP) contract research organization operating within the pre-clinical drug development space, enabling NHP research and development. 
  • B Capital Group in its Series B Preferred Stock financing of Carlsmed, a developer of a spinal implant device and medical system designed to improve outcomes and decrease the cost of healthcare for spine surgery.
  • Novo in its acquisition of Ritedose, the U.S. market leader in the development and manufacturing of sterile blow-fill-seal and unit-dose pharmaceutical products, from Humanwell and AGIC.
  • Biocon Biologics, a biopharmaceutical company that develops affordable biosimilars, novel biologics & complex APIs, in its agreement with Viatris, a provider of access to medicines, advances sustainable operations, develops innovative solutions and leverages their collective expertise to improve patient health.
  • Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, in its acquisition of Casimir, a U.S.-based CRO.

Regulatory

  • Represents medical device trade association in connection with code of ethics and compliance benchmarking.
  • Represents multiple global medical device manufacturers in connection with the development and execution of global compliance programs, including preparing compliance policies and advising on internal controls and systems.
  • Counsels multiple advanced laboratory testing companies on all manner of compliance, coverage and reimbursement, fraud and abuse, health care regulatory and government affairs-related matters.
  • Advises genetic testing companies on coverage, reimbursement, and compliance issues, including addressing payor disputes.
  • Advises multiple late-stage drug companies on matters related to commercial launch, including drug pricing, payor contracting, compliance program set-up, transparency requirements, and patient assistance and support programs.
  • Counsels nationwide chain of physician practice groups on health care regulatory and compliance matters.
  • Counsels nationwide chain of fertility and reproductive clinics on health care regulatory and compliance matters.
  • Advises women’s health and digital health technology companies on legal and regulatory implications of commercial models.
  • Counsels home medical equipment and infusion company on compliance with Medicare & Medicaid requirements.
  • Represents independent sales organizations in connection with the negotiation of service agreements with large pharmaceutical companies.
  • Counsels direct-to-consumer laboratory testing start-up on corporate and regulatory requirements associated with its business model.
  • Represents telehealth-based therapy company on compliance, corporate, and regulatory requirements in connection with launch.
  • Provides compliance counseling to early-stage pharmaceutical companies in connection with clinical research arrangements and interactions with healthcare providers.

 

Professional Experience

Prior to joining Goodwin, Mr. Wetzel held several executive positions in the life sciences industry.

  • Associate General Counsel & Chief Compliance Officer of GRAIL, Inc.
  • Vice President & Deputy General Counsel, AdvaMed
  • Senior Counsel, Global Compliance & Ethics, Boston Scientific

Mr. Wetzel began his career as an associate at two global law firms, advising health care and life sciences companies on a variety of health care fraud and abuse, billing and reimbursement, and transparency-related matters.

Professional Activities

Mr. Wetzel serves as Chair of the AdvaMed PRIDE Leadership Network, the medical technology industry’s LGBTQ diversity initiative.In addition, he has also held several leadership positions with the American Health Law Association (AHLA), including serving on AHLA’s Diversity & Inclusion Council (2014–2017) and Quality Council (2017–2019). He currently is Chair of the AHLA’s Fraud & Abuse Practice Group, the association’s largest specialty group.

Mr. Wetzel has also previously served as Secretary of the LGBT Bar Association of the District of Columbia (2016–2019), and he is a 2015 Fellow of the Leadership Council on Legal Diversity.

A trained executive and career coach, Mr. Wetzel serves on the Board of Directors for the World War II Foundation, a nonprofit organization that produces award-winning documentary films about World War II.

In The News

相关新闻

ACTUALITÉS

MELDUNGEN

Credentials

专业资格

RÉFÉRENCES

WERDEGANG

Education

J.D., 2004
Georgetown University
(cum laude)
B.A., Government, 2001
Georgetown University
(magna cum laude)

Admissions

Bar

District of Columbia
Maryland

Languages

语言

LANGUES

Sprachen

English
French
Profile Image
Get In Touch
联系我们
NOUS CONTACTER
Kontakt
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
搜寻其他律师
Recherche par Pratique
ANWALTSSUCHE